References
- Taher AT, Musallam KM, Cappellini MD. β-Thalassemias. N Engl J Med. 2021;384(8):727–743. doi:10.1056/NEJMra2021838.
- Xiong F, Huang Q, Chen X, et al. A melting curve analysis-based PCR assay for one-step genotyping of β-thalassemia mutations a multicenter validation. J Mol Diagn. 2011;131(4):427–435. doi:10.1016/j.jmoldx.2011.03.005.
- Weatherall DJ. Pathophysiology of thalassaemia. Baillieres Clin Haematol. 1998;11(1):127–146. doi:10.1016/S0950-3536(98)80072-3.
- Nienhuis AW, Nathan DG. Pathophysiology and clinical manifestations of the β-thalassemias. Cold Spring Harb Perspect Med. 2012;2(12):a011726–a011726. doi:10.1101/cshperspect.a011726.
- Xu XM, Zhou YQ, Luo GX, et al. The prevalence and spectrum of alpha and beta thalassaemia in Guangdong Province: implications for the future health burden and population screening. J Clin Pathol. 2004;57(5):517–522. doi:10.1136/jcp.2003.014456.
- Huang LF, Yu LL, Nikuze L, et al. Spectrum of β-thalassemia mutations in some areas of Guangxi Zhuang autonomous region of Southern China: a study on a pediatric population aged 0–15 years. Hemoglobin. 2021;45(5):318–321. doi:10.1080/03630269.2022.2041435.
- Gravia A, Chondrou V, Sgourou A, et al. Individualizing fetal hemoglobin augmenting therapy for β-type hemoglobinopathies patients. Pharmacogenomics. 2014;15(10):1355–1364. doi:10.2217/pgs.14.101.
- Sripichai O, Fucharoen S. Fetal hemoglobin regulation in β-thalassemia: heterogeneity, modifiers and therapeutic approaches. Expert Rev Hematol. 2016;9(12):1129–1137. doi:10.1080/17474086.2016.1255142.
- Steinberg MH. Targeting fetal hemoglobin expression to treat β hemoglobinopathies. Expert Opin Ther Targets. 2022;26(4):347–359. doi:10.1080/14728222.2022.2066519.
- Zhou D, Liu K, Sun CW, et al. KLF1 regulates BCL11A expression and gamma to beta-globin gene switching. Nat Genet. 2010;42(9):742–744. doi:10.1038/ng.637.
- Xie XM, Liu YN, Li J, et al. A Krüppel-like factor 1 gene mutation ameliorates the severity of β-thalassemia: a case report. Hemoglobin. 2019;43(2):137–139. doi:10.1080/03630269.2019.1607373.
- Khamphikham P, Sripichai O, Munkongdee T, et al. Genetic variation of Krüppel-like factor 1 (KLF1) and fetal hemoglobin (HbF) levels in β0-thalassemia/HbE disease. Int J Hematol. 2018;107(3):297–310. doi:10.1007/s12185-017-2357-3.
- Liu D, Zhang X, Yu L, et al. KLF1 mutations are relatively more common in a thalassemia endemic region and ameliorate the severity of β-thalassemia. Blood. 2014;124(5):803–811. doi:10.1182/blood-2014-03-561779.